These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 482818)

  • 41. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 42. Short course chemotherapy for lymph node tuberculosis: final report at 5 years. British Thoracic Society Research Committee.
    Br J Dis Chest; 1988 Jul; 82(3):282-4. PubMed ID: 3073808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New drugs in antitubercular therapy].
    Favez G
    Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509
    [No Abstract]   [Full Text] [Related]  

  • 46. [Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
    Wipf R
    Rev Med Suisse Romande; 1979 Apr; 99(4):205-13. PubMed ID: 504855
    [No Abstract]   [Full Text] [Related]  

  • 47. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 48. [An attempt to work out highly efficient short-course regimens by model experiments in mouse tuberculosis (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1978 May; 53(5):295-8. PubMed ID: 671951
    [No Abstract]   [Full Text] [Related]  

  • 49. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
    Aluoch JA
    East Afr Med J; 1979 Mar; 56(3):121-6. PubMed ID: 487976
    [No Abstract]   [Full Text] [Related]  

  • 52. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 53. Tuberculosis in Acukland.
    Swinburn PD
    N Z Med J; 1973 Dec; 78(505):520-5. PubMed ID: 4205888
    [No Abstract]   [Full Text] [Related]  

  • 54. Tuberculosis and renal transplantation.
    Zaragoza RM; Hernandez A; Treviño M; Diliz HS; Alvarez L
    Transplant Proc; 1996 Dec; 28(6):3309. PubMed ID: 8962285
    [No Abstract]   [Full Text] [Related]  

  • 55. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
    Szymański A; Walecki J; Czaplińska-Jóźwiak E; Kuczborska Z; Gaik A; Bilczak Z; Swiatnicka I; Swica T; Zdawski T
    Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
    [No Abstract]   [Full Text] [Related]  

  • 56. [INH and rifampicin dosage at the beginning of tuberculosis treatment].
    Peltier G; Frey N; Legrand M; Teyssier L
    Nouv Presse Med; 1977 Sep; 6(30):2692. PubMed ID: 909763
    [No Abstract]   [Full Text] [Related]  

  • 57. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
    Özkaya E
    Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [RMP and INH plasma levels in comparison to aminotransferase behavior during a tuberculostatic threefold combination therapy].
    Knop P; Kindler U; Austerhoff A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1593-6. PubMed ID: 347790
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rifampicin in the treatment of tuberculosis].
    Mattson K
    Duodecim; 1973; 89(11):807-17. PubMed ID: 4758893
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
    Peters U; Hausamen TU; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2381-6. PubMed ID: 4426257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.